Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

Affiliations

• ¹ Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; INSERM U1170, Gustave Roussy, Villejuif.
• ² Hematology Department, Gustave Roussy, Villejuif.
• ³ Hematology Department, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif.
• ⁴ Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; INSERM U1018, Gustave Roussy, Villejuif.
• ⁵ Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif.
• ⁶ Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif.
• ⁷ Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.
• ⁸ DITEP, Gustave Roussy, Villejuif.
• ⁹ Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; Plateforme de Recherche Gustave Roussy, Centre de Ressources Biologiques, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Villejuif.
• ¹⁰ Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; INSERM U1170, Gustave Roussy, Villejuif, France; Hematology Department, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif.
• ¹¹ INSERM U1170, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif.